Complementary vascular and matrix regulatory pathways underlie the beneficial mechanism of action of sorafenib in liver fibrosis.
Thabut D, Routray C, Lomberk G, Shergill U, Glaser K, Huebert R, Patel L, Masyuk T, Blechacz B, Vercnocke A, Ritman E, Ehman R, Urrutia R, Shah V.
Thabut D, et al. Among authors: shah v.
Hepatology. 2011 Aug;54(2):573-85. doi: 10.1002/hep.24427. Epub 2011 Jun 26.
Hepatology. 2011.
PMID: 21567441
Free PMC article.